Trial Profile
A Pilot Study to Characterize the Immune Response Induced by a Commercial Varicella Zoster Virus Vaccine in Healthy Adult Females in Nairobi, Kenya
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics
- Acronyms KAVI-VZV-001
- 14 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 05 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Aug 2015 New trial record